Search Results 1021-1030 of 15342 for alt

1. A Rollover Study To Further Evaluate The Safety And Efficacy Of Palovarotene Capsules In Male And Female Participants Aged ≥ 14 Years With Fibrodysplasia Ossificans Progressiva (FOP) Who Have Completed The Relevant Parent Studies. - Mayo Clinic

   - Elevated aspartate aminotransferase (AST) or alanine aminotransferase (ALT) > 2.5 × ULN. - Fasting triglycerides > 400 mg/dL with or without therapy ...

2. Efficacy And Safety Of Maribavir In Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory Or Resistant To Treatment - Mayo Clinic

   Serum aspartate aminotransferase (AST) >5 times upper limit of normal (ULN) at screening, or serum alanine aminotransferase (ALT) >5 times ULN at screening ...

3. Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery - Mayo Clinic

   Serum alanine transaminase (ALT) < 2.5 x ULN. Tissue acquisition: Patient must agree to provide the required research biopsies at baseline, week 4 and at ...

4. Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma - Mayo Clinic

   Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) ≤ 3 x ULN; Negative serum pregnancy test obtained for females of child-bearing potential ...

5. Lintuzumab-Ac225 in Older Acute Myeloid Leukemia (AML) Patients - Mayo Clinic

   Bilirubin ≤ 2.0 mg/dl; AST and ALT < 5.0 times the ULN; Eastern Cooperative Oncology Group (ECOG) Performance Status ≤ 3. Exclusion Criteria: Patients with ...

6. Anemia Studies in Chronic Kidney Disease: Erythropoiesis Via a Novel Prolyl Hydroxylase Inhibitor Daprodustat-Dialysis (ASCEND-D) - Mayo Clinic

   Alanine transaminase (ALT): >2x upper limit of normal (ULN) at screening. Bilirubin: >1.5xULN at screening. Current unstable liver or biliary disease per ...

7. Phase Ib Study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer - Mayo Clinic

   * AST(SGOT)/ALT(SGPT) ≤ 2.5x × institutional ULN or ≤5 × institutional ULN for participants with documented liver metastases * Creatinine clearance ≥ 51 ...

8. Trial of Sequential Treatment of Multiple Myeloma with Antibody Therapy - Mayo Clinic

   Alanine aminotransferase (ALT) and Aspartate transaminase (AST) 3 x ULN;; PT/INR/aPTT ≤ 1.5 x ULN OR if patient is receiving anticoagulant therapy and PT ...

9. Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF) - Mayo Clinic

   Elevation of AST, ALT, or bilirubin >2 × ULN; Primary sclerosing cholangitis with elevated transaminases. Exclusion Criteria - Optional Open-Label Extension ...

10. Toxicology and Pharmacology Shared Resource - Department of Molecular Medicine - Mayo Clinic Research

    ... (ALT) U/L, aspartate aminotransferase (AST) U/L, total bilirubin (TBIL) mg/dL, albumin (ALB) g/dL and total protein (TP) g/dL. To run this test, 150 µL of ...